Phase 2 Plasma Cell Disorder Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Plasma Cell Disorder

University of Maryland, Baltimore30 enrolled1 locationNCT07075510

Recruiting

Phase 2

Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration

Plasma Cell DisordersSolitary Bone PlasmacytomaPlasmacytoma of Bone

Institute of Hematology & Blood Diseases Hospital, China21 enrolled1 locationNCT07115667

Recruiting

Phase 1Phase 2

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Multiple MyelomaPlasma Cell Disorder

Heidelberg Pharma AG78 enrolled16 locationsNCT04879043